Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver
disease worldwide. It affects an estimated 20% of the general population, based on cohort …

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is a common cause of
abnormal LFTs in primary care, but there are no data defining its contribution nor reporting …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide
prevalence of 25%. In the United States, NAFLD and its subtype, nonalcoholic …

Background & Aims The development of non-invasive liver fibrosis tests may enable earlier
identification of patients with non-alcoholic fatty liver disease (NAFLD) requiring referral to …

Background Non-alcoholic fatty liver disease (NAFLD) is increasingly widespread with an
overall global estimated prevalence of 25%. Type 2 diabetes Mellitus (T2DM) is a key …

Objective Non-alcoholic fatty liver disease (NAFLD) is the leading cause of end-stage liver
diseases worldwide. Understanding NAFLD prevalence and trends over time at the global …

Background. Fatty liver index (FLI) is a non-invasive tool used to stratify the risk of non-
alcoholic fatty liver disease (NAFLD) in population studies; whether it can be used to …

Background and aims Nonalcoholic fatty liver disease (NAFLD) subjects with fibrosis
stage≥ 2 are at high risk for mortality. We aimed to provide national estimates and temporal …

Non-alcoholic fatty liver disease (NAFLD) has a prevalence of 25–30% in unselected
populations and has become the main reason for referrals to hepatology services. From the …

Background & Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) is
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …